The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Treatment of relapsed small cell lung cancer in the real-world: A comparison of platinum-etoposide rechallenge and cyclophosphamide-doxorubicin-vincristine (CAV) chemotherapy.

Deepro  Chowdhury

No Relationships to Disclose

Mathieu  McKinnon

No Relationships to Disclose

Paul  Wheatley-Price

Honoraria - AstraZeneca Canada; Bayer; Merck; Novartis; Sanofi

Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Guardant Health; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Merck; Novartis; Pfizer; Roche Canada; Sanofi

Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche Canada (Inst)

Sara  Moore

Honoraria - AstraZeneca; Bristol-Meyers Squibb

Research Funding - AstraZeneca (Inst)